These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9655845)

  • 1. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
    Egan CT; Herrick-Davis K; Teitler M
    J Pharmacol Exp Ther; 1998 Jul; 286(1):85-90. PubMed ID: 9655845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
    Herrick-Davis K; Grinde E; Teitler M
    J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
    Purohit A; Herrick-Davis K; Teitler M
    Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model.
    Roth BL; Choudhary MS; Khan N; Uluer AZ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):576-83. PubMed ID: 9023266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
    Rauser L; Savage JE; Meltzer HY; Roth BL
    J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ; Gouble A; Wurch T
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists.
    Egan C; Herrick-Davis K; Teitler M
    Ann N Y Acad Sci; 1998 Dec; 861():136-9. PubMed ID: 9928250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
    Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
    Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
    Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J; Dernovici S; Ribeiro P
    J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.
    Weiner DM; Burstein ES; Nash N; Croston GE; Currier EA; Vanover KE; Harvey SC; Donohue E; Hansen HC; Andersson CM; Spalding TA; Gibson DF; Krebs-Thomson K; Powell SB; Geyer MA; Hacksell U; Brann MR
    J Pharmacol Exp Ther; 2001 Oct; 299(1):268-76. PubMed ID: 11561089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization.
    Gray JA; Compton-Toth BA; Roth BL
    Biochemistry; 2003 Sep; 42(36):10853-62. PubMed ID: 12962510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating mutations of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Egan C; Teitler M
    J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.
    Westphal RS; Backstrom JR; Sanders-Bush E
    Mol Pharmacol; 1995 Aug; 48(2):200-5. PubMed ID: 7651352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
    Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.
    Purohit A; Smith C; Herrick-Davis K; Teitler M
    Psychopharmacology (Berl); 2005 May; 179(2):461-9. PubMed ID: 15821958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis.
    Ganguli SC; Park CG; Holtmann MH; Hadac EM; Kenakin TP; Miller LJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):593-8. PubMed ID: 9694908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.